FINALLY!!!
These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all.
n a sweaty Sunday morning in August of last year, Jamilah George was on the 16th floor of the historic Brown Hotel in Louisville, leading a spiritual service of sorts. George, a doctoral candidate in clinical psychology at the University of Connecticut who also holds a master’s degree in divinity from Yale University, asked the audience to shout out the names of ancestors or people they admired. With each name, George performed a libation ritual, pouring water into a leafy green plant, stationed at the front of the podium, as a gesture of thanks. “Maya Angelou,” called out one audience member. “Mama Lola,” called another. The names kept coming: Toni Morrison. Audre Lorde. Mahatma Gandhi. Harriet Tubman.
George, who had been part of a team at U-Conn. running the only clinical trial to study the effects of the psychotropic drug MDMA on post-traumatic stress disorder with participants of color, wanted the audience to connect with its cultural lineages before she started her presentation — a bracing call for inclusion and social justice within the burgeoning world of psychedelic healing. It’s a world that holds great promise but is overwhelmingly White and economically privileged. Part of the problem, as George sees it, is that academia has lost its connection to the histories of these consciousness-altering substances (also known as entheogens), many of which have been used by Indigenous cultures for physical and psychological healing for thousands of years. (more)
=============================================================
Thesis: use of psilocybin & Ecstacy to treat PTSD. But over-policing of non-white minorities may present a barrier to their inclusion in these therapies.
These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all.
n a sweaty Sunday morning in August of last year, Jamilah George was on the 16th floor of the historic Brown Hotel in Louisville, leading a spiritual service of sorts. George, a doctoral candidate in clinical psychology at the University of Connecticut who also holds a master’s degree in divinity from Yale University, asked the audience to shout out the names of ancestors or people they admired. With each name, George performed a libation ritual, pouring water into a leafy green plant, stationed at the front of the podium, as a gesture of thanks. “Maya Angelou,” called out one audience member. “Mama Lola,” called another. The names kept coming: Toni Morrison. Audre Lorde. Mahatma Gandhi. Harriet Tubman.
George, who had been part of a team at U-Conn. running the only clinical trial to study the effects of the psychotropic drug MDMA on post-traumatic stress disorder with participants of color, wanted the audience to connect with its cultural lineages before she started her presentation — a bracing call for inclusion and social justice within the burgeoning world of psychedelic healing. It’s a world that holds great promise but is overwhelmingly White and economically privileged. Part of the problem, as George sees it, is that academia has lost its connection to the histories of these consciousness-altering substances (also known as entheogens), many of which have been used by Indigenous cultures for physical and psychological healing for thousands of years. (more)
=============================================================
Thesis: use of psilocybin & Ecstacy to treat PTSD. But over-policing of non-white minorities may present a barrier to their inclusion in these therapies.
I think they would benefit terminally ill people. Psychedelics are supposed to diminish, if not eliminate, the fear of death.
One pill makes you largerFINALLY!!!
Timothy Leary is being vindicated.
(Of course, the difference is Leary was a scientist. This lady sounds like a nutjob.)
They do. With guidance, they appear to allow one to reconcile with the impending future.
Having played around quite a bit some decades ago, I can see why. You inhabit a new perspective, if you've got a few working neurons.
I've taken a few drugs in my time, but never psychedelics. They've always scared me a little but I find them intriguing as well. I think the biggest reason I haven't tried any yet is that most last for an incredibly long time. Not sure if I want to commit several hours to possibly having a bad experience. I know DMT is a very short experience, but I wouldn't have a clue where to get it.
I raised cactus that contained mescaline. I developed a method for extracting the mescaline without using any flammable or toxic solvents. Taken in the morning, I would be intoxicated for at least 6 hours.
The one I would like to try is 5-methoxyDMT which is found in glands in the Sonoran Desert Toad. Incredible rush, short acing. The DMTs are called the Business Man's Trip because you could do them over lunch break. Unfortunately for experimenter's, that toad is Protected.
My degree is in chemistry. Mescaline is insoluble in water - at room temperature. But it is very soluble in hot/boiling water.Yeah, six hours is a long time. How did you extract the mescaline without toxic solvents? DMT supposedly 5-10 minutes, or slightly longer. I guess I need to find me a toad.
My degree is in chemistry. My process doesn't belong here.
My degree is in chemistry. Mescaline is insoluble in water - at room temperature. But it is very soluble in hot/boiling water.
From what I understand that there is some promising research on use of MDMA in people with PTSD. I have looked into it, but it is in the early stages and I am waiting to see what the success rates are.
These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all.
n a sweaty Sunday morning in August of last year, Jamilah George was on the 16th floor of the historic Brown Hotel in Louisville, leading a spiritual service of sorts. George, a doctoral candidate in clinical psychology at the University of Connecticut who also holds a master’s degree in divinity from Yale University, asked the audience to shout out the names of ancestors or people they admired. With each name, George performed a libation ritual, pouring water into a leafy green plant, stationed at the front of the podium, as a gesture of thanks. “Maya Angelou,” called out one audience member. “Mama Lola,” called another. The names kept coming: Toni Morrison. Audre Lorde. Mahatma Gandhi. Harriet Tubman.
George, who had been part of a team at U-Conn. running the only clinical trial to study the effects of the psychotropic drug MDMA on post-traumatic stress disorder with participants of color, wanted the audience to connect with its cultural lineages before she started her presentation — a bracing call for inclusion and social justice within the burgeoning world of psychedelic healing. It’s a world that holds great promise but is overwhelmingly White and economically privileged. Part of the problem, as George sees it, is that academia has lost its connection to the histories of these consciousness-altering substances (also known as entheogens), many of which have been used by Indigenous cultures for physical and psychological healing for thousands of years. (more)
=============================================================
Thesis: use of psilocybin & Ecstacy to treat PTSD. But over-policing of non-white minorities may present a barrier to their inclusion in these therapies.
Psilocybin from magic mushrooms is also being evaluated for its effect in psychiatry. Timothy Leary used it in studies at Harvard but he was using pure, synthetic drug made by Sandoz.From what I understand that there is some promising research on use of MDMA in people with PTSD. I have looked into it, but it is in the early stages and I am waiting to see what the success rates are.
They are also using some treatments in depression, etc....which are showing promise.
I find it fascinating the research being done on this...and I wait hoping that it is a success, because this could be something that will help people like me. I have PTSD that has shown to be fairly resistant to treatment via medication...behavior has helped to make it tolerable. ..but the meds turn me into a zombie so I threw them out some time ago...except the medication that helps me with nightmares...and that is all I take now.Psilocybin from magic mushrooms is also being evaluated for its effect in psychiatry. Timothy Leary used it in studies at Harvard but he was using pure, synthetic drug made by Sandoz.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?